Elsevier

Molecular Brain Research

Volume 32, Issue 2, September 1995, Pages 261-270
Molecular Brain Research

Research report
Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN)

https://doi.org/10.1016/0169-328X(95)00086-8Get rights and content

Abstract

Corticotropin-releasing factor (CRF) plays a role in coordinating endocrine, autonomic, and behavioral responses to stressful stimuli. Benzodiazepines exert many effects which oppose those of CRF, including anxiolysis and suppression of the pituitary-adrenal axis. In the present study, we employed in situ analysis of CRF heteronucleous RNA (hnRNA) and c-fos mRNA to assess stimulus-induced CRF gene transcription rate following stress and its modulation by chlordiazepoxide (CDP). Male albino rats were exposed to restraint stress for 30 min and sacrificed 30 and 120 min after the onset of stress. Either CDP or vehicle was given intraperitoneally 60 min before stress. To determine plasma ACTH levels by immunoradiometric assay, another group of rats was decapitated 10 min after the onset of restraint stress. Restraint stress induced rapidly and significantly c-fos mRNA and CRF hnRNA expression in the PVN at the 30 min time point. Increases in both RNA copies were significantly inhibited by administration of CDP at doses of 5 and 10 mg/kg. CRF mRNA concentrations were increased significantly in the PVN 120 min after stress and again, CDP attenuated significantly these increases in the PVN. The plasma ACTH increase in response to stress was inhibited significantly by CDP administration at every dose tested. CDP did not change CRF mRNA levels in the non-sressed animal. We conclude that the suppression of cellular activities in the PVN following stress by CDP, while not established directly or indirectly, coincides with the inhibition of CRF gene transcription in the PVN, and that CDP inhibits the hypothalamo-pituitary adrenal (HPA) axis through suppression of activation of neurons, CRF gene transcription, and CRF biosynthesis in the PVN.

References (63)

  • R.A. Anderson et al.

    Analysis of benzodiazepine binding sites in rat pituitary gland

    Brain Res.

    (1994)
  • F.A. Antoni

    Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor

    Endocrine Rev.

    (1986)
  • D.L. Autelitano et al.

    Changes in rat pituitary nuclear and cytoplasmic pro-opiomelanocortin RNAs associated with adrenalectomy and glucocorticoid replacement

    Mol. Cell Endocrinol.

    (1989)
  • H.A. Baldwin et al.

    CRF antagonist reverses the ‘anxiogenic’ response to ethanol withdrawal in the rat

    Psychopharmacology

    (1991)
  • C.H.M. Beck et al.

    Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment

    J. Neurosci.

    (1995)
  • H. Benson et al.

    Hypotensive effects of chlordiazepoxide, amobarbital and chlorpromazine on behaviorally induced elevated blood pressure in the squirrel monkey

    J. Pharmacol Exp. Ther.

    (1970)
  • D.R. Britton et al.

    A sensitive open field measure of anxiolytic drug activity

    Pharmacol. Biochem. Behav.

    (1981)
  • K.T. Britton et al.

    Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test

    Psychopharmacology

    (1985)
  • C. Brown et al.

    Autoradiographic localization of benzodiazepine receptors in the rat anterior pituitary gland

    Eur. J. Pharmacol.

    (1984)
  • G. Bruni et al.

    Plasma A.C.T.H. and cortisol levels in benzodiazepine treated rats

    Pharmacol. Res. Commun.

    (1980)
  • S. Ceccatelli et al.

    Expression of c-Fos immunoreactivity in transmitter-characterized neurons after stress

  • R.K.W. Chan et al.

    A comparison of two immediate early genes, c-fos and NGFI-B, as markers for functional activation in stress-related neuroendocrine circuitry

    J. Neurosci.

    (1993)
  • E.B. DeSouza et al.

    Peripheral-type benzodiazepine receptors in endocrine organs: autoradiographic localization in rat pituitary, adrenal and testis

    Endocrinology

    (1985)
  • M. Dragunow et al.

    The use of c-fos as a metabolic marker in neuronal pathway tracing

    J. Neurosci. Methods

    (1989)
  • A.J. Dunn et al.

    Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

    Brain Res. Rev.

    (1990)
  • R.T. Fremeau et al.

    Regulation of pro-opiomelanocortin gene transcription in individual cell nuclei

    Science

    (1986)
  • W.E. Haefely et al.

    Recent advances in the molecular pharmacology of benzodiazepine receptors and in the structure activity relationship of their agonists and antagonists

    Adv. Drug Res.

    (1985)
  • J.P. Herman et al.

    In situ hybridization analysis of arginine vasopressin gene transcription using intron-specific probes

    Mol. Endocrinol.

    (1991)
  • J.P. Herman et al.

    Rapid regulation of corticotropin-releasing hormone gene transcription in vivo

    Mol. Endocrinol.

    (1992)
  • M. Helig et al.

    Corticotropinreleasing factor and neuropeptide Y: role in emotional integration

    Trends Neurosci.

    (1994)
  • E.W. Hillhouse et al.

    Effects of noradrenalin and g-aminobutyric acid on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro

    J. Endocrinol.

    (1989)
  • T. Imaki et al.

    Widespread expression of corticotropin-releasing factor messenger RNA and immunoreactivity in the rat olfactory bulb

    Brain Res.

    (1989)
  • T. Imaki et al.

    Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress

    J. Neurosci.

    (1991)
  • T. Imaki et al.

    Early induction of c fos precedes increased expression of corticotropin-releasing factor messenger ribonucleic acid in the paraventricular nucleus after immobilization stress

    Endocrinology

    (1992)
  • T. Imaki et al.

    Chlordiazepoxide attenuates stress-induced CRF mRNA accumulation in the PVN

    Brain Res.

    (1993)
  • T. Imaki et al.

    Glucocorticoids modulate neuronal activity, CRF gene transcription and CRF production following stress in paraventricular nucleus (PVN) in rats

    Soc. Endocrinol. Abstr.

    (1994)
  • M. Irwin et al.

    Benzodiazepines antagonize central corticotropin releasing hormone-induced suppression of natural killer cell activity

    Brain Res.

    (1993)
  • A. Itoh et al.

    A sensitive immunoradiometric assay for human adrenocorticotropic hormone

    Biomed. Res.

    (1989)
  • K.T. Kalogeras et al.

    In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications

    J. Clin. Endocrinol. Metab.

    (1990)
  • T. Kosaka et al.

    Catecholaminergic neurons containing GABA-like and/or glutamic acid decarboxylase-like immunoreactivities in various brain regions of the rat

    Exp. Brain Res.

    (1987)
  • R. Krulik et al.

    Effects of chlordiazepoxide on stress in rats

    Life Sci.

    (1971)
  • Cited by (58)

    • Midazolam treatment before re-exposure to contextual fear reduces freezing behavior and amygdala activity differentially in high- and low-anxiety rats

      2015, Pharmacology Biochemistry and Behavior
      Citation Excerpt :

      Accordingly, infusing the GABA-receptor agonist muscimol into the BLA impaired both extinction learning and fear renewal (Herry et al., 2008). Benzodiazepines have been demonstrated to suppress HPA axis activity, thus attenuating the stress-induced activation of neurons (as measured by CRF mRNA and c-Fos mRNA) and the anxiogenic effects of CRF (Krulik and Cerny, 1971; Britton et al., 1985; Swerdlow and Britton, 1994; Imaki et al., 1995). In the present study, midazolam attenuated re-conditioning-induced CRF expression in the MeA and plasma corticosterone concentration in the LR rats compared with those parameters in the control and HR groups.

    • Magnesium deficiency induces anxiety and HPA axis dysregulation: Modulation by therapeutic drug treatment

      2012, Neuropharmacology
      Citation Excerpt :

      In Mg2+ deficient mice, application of the benzodiazepine diazepam reduced the hyper-reactivity of the PVN in response to a mild emotional challenge. The ability of benzodiazepines to decrease stress-induced neuronal activation in the PVN has been previously shown in mice (Imaki et al., 1995) and rats (Beck and Fibiger, 1995; de Medeiros et al., 2005). Furthermore, chronic desipramine treatment via the drinking water normalised CRH overexpression in the PVN and elevated ACTH plasma levels.

    • Chlordiazepoxide and lavender oil alter unconditioned anxiety-induced c-fos expression in the rat brain

      2011, Behavioural Brain Research
      Citation Excerpt :

      There are thus a number of reasons to expect that CDP would reduce anxiety and change c-fos expression as was found in the brain regions studied. The effect of CDP on c-fos expression in PVN replicates an earlier finding [29], where it was argued that CDP suppressed the cellular activation caused by CRF release and ACTH secretion. A different effect was seen in the CeA, where CDP promoted expression of c-fos after stress, as found previously [26,27,38].

    View all citing articles on Scopus
    View full text